Cabot Corp (CBT) director Vanlancker reports 2,298-share deferral
Rhea-AI Filing Summary
Cabot Corporation director Thierry Vanlancker reported an acquisition of company common stock through a compensation-related deferral. On January 8, 2026, he acquired 2,298 shares of Cabot common stock at a stated price of $0 per share, classified as an acquisition transaction. After this transaction, he beneficially owned 4,902 Cabot shares in total, held directly.
According to the footnote, these shares have been deferred under Cabot's Non-Employee Directors' Deferral Plan, meaning they arise from the director compensation program rather than an open‑market purchase. The filing indicates this report is made by a single reporting person in his capacity as a director of Cabot Corporation.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,298 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Cabot Corp (CBT) disclose for Thierry Vanlancker?
Cabot Corp disclosed that director Thierry Vanlancker acquired 2,298 shares of Cabot common stock on January 8, 2026, reported as an acquisition transaction.
What is Thierry Vanlancker’s role at Cabot Corp (CBT) according to this filing?
The filing identifies Thierry Vanlancker as a director of Cabot Corporation and does not list him as an officer or a 10% owner.
Is the reported Cabot Corp (CBT) transaction a direct or indirect holding for Thierry Vanlancker?
The report classifies the holdings as direct ownership (D), with 4,902 Cabot shares beneficially owned directly after the transaction.